Arginase Inhibition in Ischemia-reperfusion Injury
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The present project is designed to test the hypothesis that arginase contributes to
endothelial dysfunction induced by ischemia-reperfusion in patients with coronary artery
disease.